Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,197,011
Closed -$6.9M – 3860
2026
Q2
$6.9M Buy
2,197,011
+1,867,907
+568% +$5.84M 0.01% 1542
2026
Q1
$961K Buy
+329,104
New +$940K ﹤0.01% 2782
2025
Q4
– Sell
-1,375,400
Closed -$3.07M – 3868
2025
Q3
$3.07M Sell
1,375,400
-1,221,300
-47% -$2.79M 0.01% 1266
2025
Q2
$6.26M Buy
2,596,700
+1,294,811
+99% +$3.15M 0.01% 895
2025
Q1
$3.03M Sell
1,301,889
-292,011
-18% -$584K 0.01% 1114
2024
Q4
$2.95M Buy
+1,593,900
New +$3.53M 0.01% 1112
2024
Q3
– Sell
-431,000
Closed -$884K – 1936
2024
Q2
$884K Buy
431,000
+376,500
+691% +$857K ﹤0.01% 1301
2024
Q1
$135K Buy
+54,500
New +$142K ﹤0.01% 1966

Other funds holding ABEV

Steven Cohen's ABEV Position: Q3 2026 in Review

Steven Cohen sold out of Ambev (ABEV) in Q3 2026, closing a stake of 2,197,011 shares — an estimated $6.9M sold.

Steven Cohen first reported a position in ABEV in Q1 2024 and held it in 8 quarters. The position peaked at $6.9M in Q2 2026. 396 funds tracked by Wall St. Rank hold ABEV as of Q3 2026.

  • Steven Cohen reported no remaining Ambev position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 2,197,011 Ambev shares in Q3 2026, an estimated $6.9M.
  • Steven Cohen first reported a position in Ambev in Q1 2024 and held it in 8 quarters.
  • Steven Cohen's Ambev position peaked at $6.9M in Q2 2026.
  • 396 funds tracked by Wall St. Rank held Ambev as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.